Beranda › Limfoma Burkitt › Connecticut › Bridgeport
Uji klinis Limfoma Burkitt di Bridgeport, CT
4 studi untuk Limfoma Burkitt mencari peserta di lokasi sekitar Bridgeport (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Menerima pesertaFase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi jauhnya
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
Menerima pesertaFase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi jauhnya
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Menerima pesertaFase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi jauhnya
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Menerima pesertaFase 3
- Stony Brook University Medical Center, Stony Brook · 18 mi jauhnya
Uji klinis Limfoma Burkitt di kota lain
- Houston, TX21 studi
- Philadelphia, PA16 studi
- Milwaukee, WI16 studi
- Chicago, IL15 studi
- Cincinnati, OH13 studi
- New York City, NY13 studi
- Atlanta, GA12 studi
- Aurora, CO11 studi
- Seattle, WA11 studi
- Durham, NC10 studi
- Boston, MA10 studi
- Kansas City, MO10 studi
Studi lain di Bridgeport
- Kanker Payudara21 studi
- Kanker Paru Non-Sel Kecil14 studi
- Kanker Paru13 studi
- Leukemia Mieloid Akut12 studi
- Penyakit Kardiovaskular9 studi
- Kanker (semua jenis)8 studi
- Karsinoma Sel Skuamosa Kepala dan Leher8 studi
- Kanker Metastatik7 studi
- Gagal Jantung7 studi
- Aneurisma Otak6 studi
- Mieloma Multipel6 studi
- Kanker Prostat6 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.